drugset / Trial / NCT00003686
Pilocarpine in Treating Patients With Dry Mouth Caused by Opioids
RandomizedParallel-groupTriple-blindSupportive care
Summary
RATIONALE: Pilocarpine may help to relieve dry mouth in patients receiving opioids for cancer therapy. It is not yet known whether pilocarpine is more effective than no further treatment for this condition. PURPOSE: Randomized phase III trial to determine the effectiveness of pilocarpine in treating patients who have dry mouth caused by opioids.
Timeline
- Start
- 1998-05-22
- Primary completion
- 2007-11-01
- Completion
- 2008-12-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Pilocarpine | Unknown | 5 mg | Oral |